Identification of influenza A nucleoprotein as an antiviral target.
about
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymeraseStructure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.Recent progress in structure-based anti-influenza drug designInhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomersMonomeric Nucleoprotein of Influenza A VirusThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignNew small-molecule drug design strategies for fighting resistant influenza AAirborne transmission of highly pathogenic H7N1 influenza virus in ferretsStructure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivoEstablishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and ReplicationA Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus NucleoproteinIdentification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial MalignanciesDesigning and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoproteinNovel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics ApproachesAvian influenza A H5N1 virus: a continuous threat to humans.Two years after pandemic influenza A/2009/H1N1: what have we learned?Progress of small molecular inhibitors in the development of anti-influenza virus agents.A GFP-tagged nucleoprotein-based aggregation assay for anti-influenza drug discovery and antibody development.Highly pathogenic avian influenza virus nucleoprotein interacts with TREX complex adaptor protein Aly/REFPhenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan.Influenza A virus ribonucleoproteins modulate host recycling by competing with Rab11 effectors.Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo ExperimentsThe lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation.Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.The Management of the 2009 pandemic Influenza A H1N1 virus infectionEmerging antiviral strategies to interfere with influenza virus entry.Newer influenza antivirals, biotherapeutics and combinations.Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 peptide in Marburg virus.Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.Genome rearrangement of influenza virus for anti-viral drug screeningEmerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex.High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activityNew treatments for influenzaHow to approach and treat viral infections in ICU patientsA comprehensive map of the influenza A virus replication cycleIntracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization.E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitorsInsight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolutionReduction of false positives in structure-based virtual screening when receptor plasticity is considered.
P2860
Q21089768-9EF42133-7077-4546-A253-EEB972D16166Q24632337-308558E5-0B71-41D7-8C7D-717BC7D43829Q26863710-47C079DA-7ED8-44FB-9D35-158D472EBDD5Q27673286-B4F1D90D-2A36-46A1-B5B8-5507A50864B8Q27677207-43789E73-2475-4AEA-9151-40D138B14171Q28071809-535627FC-5C40-46A6-BE4F-A6364182EE7FQ28080554-264E25A5-5287-4EE3-9113-85BF4681E8F1Q28387714-3ED9764A-E3AB-46F5-AA3F-FEA0F87CC185Q28476470-9045E45A-0E2C-4554-AF09-B222F4C54AE3Q28546724-E2DF3DDF-79AE-4B91-B1B8-2906DE2842C3Q28546866-40C04110-DD8F-48C5-99C2-0F11318F47D6Q28551855-10D7A523-D3AC-4296-9D36-F1083488A13FQ28817173-7A79F081-F759-4651-AF5A-930D5154548CQ28830618-051DADAD-7911-4E57-BD4D-F46E6E4BDFE9Q30224462-FC3962CF-738E-42DE-B953-4C43373CF14AQ30224656-D4C97984-D8EE-4D08-B05A-22C031F4843EQ30234943-8FD2D239-A04B-4A14-925D-ED9B820D1F89Q30352981-29F89B3D-E0E3-457D-BEB9-D8A247DADFDAQ30353960-6F62E1A4-542D-421F-A0DF-8CCC2442E8E6Q30377784-EA783F33-6A95-4752-BA40-2034739FCB79Q30385238-5842351F-BCF6-4585-AF0E-53230999AF41Q30393969-D32398B3-8760-40F3-82F8-4D1285196E81Q30396915-770D8797-287C-4084-B488-149F863EFBEEQ30398356-86A3C1DB-0C9B-4906-9023-64B55B07B481Q30398715-20D47BFC-A1D2-4064-8236-22F2E19E6962Q30412410-C60FE3D9-C1EC-4B95-A32D-25352F3A30FCQ30432421-D871A0E3-6A8C-4381-A852-3868C67E2E93Q30456363-9EB8ED08-03CA-4EA4-96F8-E89B27DB2F43Q30491838-CB0DC8C8-A25B-4425-98FB-559F872D256FQ34022729-94DAB077-364E-45E4-81FE-ADB14AD9483EQ34053717-E4E62E3C-9F5E-49D2-B7DB-208BCF39CE24Q34269400-E58D0E44-5B5E-4509-85E9-9127FEFDF0D0Q34320548-F8D94972-45F0-431C-B603-8CBF3CEAA40DQ34413797-771E4399-6A58-48C2-892C-B7A6332D176FQ34894660-016B10B3-9EF9-44BB-9511-55D29AF6FAEEQ35006697-B3C69E5E-402C-4EDA-9809-26A5353C30D2Q35076701-C7947F0C-729F-45B7-BD9F-3FBD7F13A746Q35289390-27AD0C36-831A-4DDE-8149-666259E7F3E8Q35563697-EE3ECFD9-DA47-4A26-9AF0-23E0B2F0A232Q35586644-192B1851-573A-436C-A9A2-649349607D58
P2860
Identification of influenza A nucleoprotein as an antiviral target.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of influenza A nucleoprotein as an antiviral target.
@ast
Identification of influenza A nucleoprotein as an antiviral target.
@en
type
label
Identification of influenza A nucleoprotein as an antiviral target.
@ast
Identification of influenza A nucleoprotein as an antiviral target.
@en
prefLabel
Identification of influenza A nucleoprotein as an antiviral target.
@ast
Identification of influenza A nucleoprotein as an antiviral target.
@en
P2093
P50
P356
P1433
P1476
Identification of influenza A nucleoprotein as an antiviral target.
@en
P2093
Bo-Jian Zheng
Che-Man Chan
Guanhua Chen
Jason Madar
Jian-Dong Huang
Lai-Shan Lau
P2888
P304
P356
10.1038/NBT.1638
P577
2010-05-30T00:00:00Z